These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 2022221)

  • 1. Value of routine citrate analysis and calcium/citrate ratio in calcium urolithiasis.
    Höbarth K; Hofbauer J
    Eur Urol; 1991; 19(2):165-8. PubMed ID: 2022221
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Urinary citrate excretion in patients with urolithiasis and normal subjects.
    Nikkilä M; Koivula T; Jokela H
    Eur Urol; 1989; 16(5):382-5. PubMed ID: 2776809
    [TBL] [Abstract][Full Text] [Related]  

  • 3. On the relation between citrate and calcium in normal and stone-former subjects.
    Conte A; Roca P; Gianotti M; Grases F
    Int Urol Nephrol; 1990; 22(1):7-12. PubMed ID: 2380005
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The significance of citrate excretion and calcium/citrate quotients in urine in patients with calcium calculi].
    Hofbauer J; Höbarth K; Zechner O
    Z Urol Nephrol; 1990 Nov; 83(11):597-602. PubMed ID: 2100085
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Calcium-to-Citrate Ratio Distinguishes Solitary and Recurrent Urinary Stone Forming Children.
    DeFoor W; Jackson E; Schulte M; Alam Z; Asplin J
    J Urol; 2017 Aug; 198(2):416-421. PubMed ID: 28365270
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Urinary citrate excretion in stone-formers and normal controls.
    Welshman SG; McGeown MG
    Br J Urol; 1976 Feb; 48(1):7-11. PubMed ID: 1268467
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Urinary glycosaminoglycan excretion in normal and stone-forming subjects: significant disturbance in recurrent stone formers.
    Nikkilä MT
    Urol Int; 1989; 44(3):157-9. PubMed ID: 2749930
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biochemical risk factors for stone formation in a Scottish paediatric hospital population.
    MacDougall L; Taheri S; Crofton P
    Ann Clin Biochem; 2010 Mar; 47(Pt 2):125-30. PubMed ID: 20144971
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Citrate and kidney stones].
    Osther PJ
    Ugeskr Laeger; 1993 Nov; 155(47):3835-9. PubMed ID: 8256384
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Urinary citrate, bone resorption and intestinal alkali absorption in stone formers with fasting hypercalciuria.
    Messa P; Mioni G; Paganin L; Cruciatti A; Greco PL; Turrin D
    Scanning Microsc; 1994; 8(3):531-8; discussion 538-9. PubMed ID: 7747155
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acute acid load in recurrent oxalate stone formers.
    Knispel HH; Fitzner R; Kaiser M; Butz M
    Urol Int; 1988; 43(2):93-6. PubMed ID: 3388639
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Urinary citrate excretion in normal persons and patients with idiopathic calcium urolithiasis.
    Hosking DH; Wilson JW; Liedtke RR; Smith LH; Wilson DM
    J Lab Clin Med; 1985 Dec; 106(6):682-9. PubMed ID: 4067380
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Insulin resistance and low urinary citrate excretion in calcium stone formers.
    Cupisti A; Meola M; D'Alessandro C; Bernabini G; Pasquali E; Carpi A; Barsotti G
    Biomed Pharmacother; 2007 Jan; 61(1):86-90. PubMed ID: 17184967
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Estimation of 24-h excretion of some promotors and inhibitors of crystallization and degree of urine saturation with calcium oxalate in calcium urinary calculi].
    Boruczkowska A
    Pol Arch Med Wewn; 1994 Oct; 92(4):289-98. PubMed ID: 7854956
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of calcium, oxalate, and citrate interaction in idiopathic calcium urolithiasis in children.
    Milosević D; Batinić D; Konjevoda P; Blau N; Stambuk N; Nizić L; Vrljicak K; Batinić D
    J Chem Inf Comput Sci; 2003; 43(6):1844-7. PubMed ID: 14632431
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Value of repeated analyses of 24-hour urine in recurrent calcium urolithiasis.
    Höbarth K; Hofbauer J; Szabo N
    Urology; 1994 Jul; 44(1):20-4; discussion 24-5. PubMed ID: 8042263
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effects of a single evening dose of alkaline citrate on urine composition and calcium stone formation.
    Berg C; Larsson L; Tiselius HG
    J Urol; 1992 Sep; 148(3 Pt 2):979-85. PubMed ID: 1507355
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Studies of urinary risk factors in urolithiasis].
    Ebisuno S; Kitagawa M; Morimoto S; Miyazaki Y; Minakata S; Yasukawa S; Fukatani T; Ohkawa T
    Hinyokika Kiyo; 1985 Jan; 31(1):1-15. PubMed ID: 3993484
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of citrate on the different phases of calcium oxalate crystallization.
    Tiselius HG; Berg C; Fornander AM; Nilsson MA
    Scanning Microsc; 1993 Mar; 7(1):381-9; discussion 389-90. PubMed ID: 8316807
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Citrate in daily and fasting urine: results of controls, patients with recurrent idiopathic calcium urolithiasis, and primary hyperparathyroidism.
    Schwille PO; Scholz D; Paulus M; Engelhardt W; Sigel A
    Invest Urol; 1979 May; 16(6):457-62. PubMed ID: 447479
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.